| Announce Date | 01/22/2026 |
| EPS Normalized Actual | $0.06 In Line |
| EPS GAAP Actual | $0.06 In Line |
| Revenue Actual | $0.446B |
| Revenue Surprise | Beat by $446M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.07333 | 4.37 | 1.97741 | 2.23051 | 1 |
| Dec 2029 | 1.99667 | 4.54 | 1.7756 | 2.54311 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.16 | -0.16 | 0.446B | -9.87% | 446M |
| FQ3 2025 (Sep 2025) | -0.12 | -0.12 | 0.504B | 3.57% | 504M |
| FQ2 2025 (Jun 2025) | -0.08 | -0.08 | 0.506B | 13.24% | 506M |
| FQ1 2025 (Mar 2025) | -0.13 | -0.13 | 0.438B | 45.43% | 438M |
| FQ4 2024 (Dec 2024) | -0.0875 | -0.0875 | 0.49B | -30% | 490M |
| FQ3 2024 (Sep 2024) | -3.35 | -3.35 | 0.486B | -9.05% | 486M |
| FQ1 2021 (Mar 2021) | 0 | 0 | 0.377B | 100% | 377M |
| FQ2 2021 (Jun 2021) | 0 | 0 | 0.327B | 100% | 327M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2030 (Dec 2030) | 0.19 | -- | 0.178 | 0.20096 | 4 |
| FQ3 2030 (Sep 2030) | 0.17 | -- | 0.15926 | 0.17981 | 8 |
| FQ2 2030 (Jun 2030) | 0.2 | -- | 0.18737 | 0.21154 | 5 |
| FQ1 2030 (Mar 2030) | 0.23 | -- | 0.21547 | 0.24327 | 4 |
| FQ4 2029 (Dec 2029) | 0.19 | -- | 0.17522 | 0.21068 | 2 |
| FQ3 2029 (Sep 2029) | 0.2 | -- | 0.19504 | 0.20333 | 7 |
| FQ2 2029 (Jun 2029) | 0.21 | -- | 0.2048 | 0.2135 | 4 |
| FQ1 2029 (Mar 2029) | 0.21 | -- | 0.2048 | 0.2135 | 4 |
| FQ4 2028 (Dec 2028) | 0.35 | -- | 0.28622 | 0.43964 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2030 (Dec 2030) | 0.96B | -- | 0.91B | 1B | 7 |
| FQ3 2030 (Sep 2030) | 0.94B | -- | 0.89B | 0.98B | 7 |
| FQ2 2030 (Jun 2030) | 0.95B | -- | 0.9B | 0.99B | 7 |
| FQ1 2030 (Mar 2030) | 1.01B | -- | 0.96B | 1.05B | 7 |
| FQ4 2029 (Dec 2029) | 0.77B | -- | 0.73B | 0.84B | 2 |
| FQ3 2029 (Sep 2029) | 0.8B | -- | 0.79B | 0.81B | 7 |
| FQ2 2029 (Jun 2029) | 0.81B | -- | 0.8B | 0.82B | 7 |
| FQ1 2029 (Mar 2029) | 0.8B | -- | 0.79B | 0.82B | 7 |
| FQ4 2028 (Dec 2028) | 1.02B | -- | 0.87B | 1.22B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
6
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.16 | -0.16 | 100% | |
| FQ3 2025 (Sep 2025) | -0.12 | -0.12 | 100% | |
| FQ2 2025 (Jun 2025) | -0.08 | -0.08 | 100% | |
| FQ1 2025 (Mar 2025) | -0.13 | -0.13 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0875 | -0.0875 | 100% | |
| FQ3 2024 (Sep 2024) | -3.35 | -3.35 | 100% | |
| FQ1 2021 (Mar 2021) | 0 | 0 | NAN% | |
| FQ2 2021 (Jun 2021) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $0.45B | $446M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $0.5B | $504M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.51B | $506M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.44B | $438M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.49B | $490M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.49B | $486M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $0.38B | $377M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $0.33B | $327M | 100% |